Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

lncRNAs GAS5 and MALAT1 Contained in Human Adipose Stem Cell (hASC)-Derived Exosomes Drive the Cell-Free Repair and Regeneration of Wounds In Vivo.

Krause-Hauch M., Patel RS., Wang B., Osborne B., Jones B., Albear P.

Prospective Study on Chronic Wound, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Int J Mol Sci (2025)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
40331955
PMCID
PMC12027045
DOI
10.3390/ijms26083479
Citations
3

Abstract (original English)

Wound healing progresses through four phases: hemostasis, inflammation, proliferation, and remodeling. Wounds may become chronic if this process is disrupted. The use of small extracellular vesicle (sEV; EVs < 200 nm) exosomes (exo; ~40-120 nm) derived from human adipose stem cells (hASCs) as a treatment for wounds is well studied. The cargo of these exosomes is of great interest as this accelerates wound healing. Our previous studies identified lncRNAs GAS5 and MALAT1 as packaged and enriched in hASC exosomes. In this study, we use a rat model to examine the effects on wound healing when hASC exosomes are depleted of GAS5 and MALAT1 . Rats were wounded and wounds were treated with 100 μg hASC exo or hASC exo -G-M every 2 days for 1 week. qPCR was completed to evaluate the molecular effects of depletion of GAS5 and MALAT1 from hASC exo . RNAseq was performed on wound tissue to evaluate the molecular mechanisms changed by hASC exo -G-M in wound healing. While hASC exo -G-M significantly improved wound healing rate compared to control wounds, healing occurred slower than in wounds treated with hASC exo that were not depleted of GAS5 and MALAT1 . Overall, this study reveals that molecular functions associated with healing are reduced in the absence of GAS5 and MALAT1 , highlighting the importance of these lncRNAs.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
ExosomesRNA, Long NoncodingWound HealingHumansAnimalsRatsMaleAdipose TissueStem CellsRegeneration

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research